cyc 202 has been researched along with (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies ((3h)2-carbomethoxy-3-(4-fluorophenyl)tropane) | Trials ((3h)2-carbomethoxy-3-(4-fluorophenyl)tropane) | Recent Studies (post-2010) ((3h)2-carbomethoxy-3-(4-fluorophenyl)tropane) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 397 | 5 | 36 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Price, DA; Sorkin, A; Zahniser, NR | 1 |
1 other study(ies) available for cyc 202 and (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane
| Article | Year |
|---|---|
Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity.
Topics: Animals; Cells, Cultured; Cocaine; Corpus Striatum; Cyclin-Dependent Kinase 5; Dopamine; Dopamine Plasma Membrane Transport Proteins; Endocytosis; Humans; Indoles; Male; Protein Kinase Inhibitors; Purines; Rats; Rats, Sprague-Dawley; Roscovitine; Swine; Synaptosomes | 2009 |